CooperCompanies Publishes 2022 Environmental, Social, and Governance Report, Shares Progress on Creating Value for Stakeholders
09 Mai 2023 - 10:15PM
CooperCompanies (NYSE: COO) today released its 2022 Environmental,
Social, and Governance (ESG) Report. It highlights the company's
progress on social and environmental issues most important to its
businesses and stakeholders, including employees, shareholders,
customers, and global communities.
In 2022, CooperCompanies manufactured a record number of
products while reducing greenhouse gas (GHG) emissions by more than
7%. A big contributor to this success was the start of the
operation of a combined heat and power (CHP) facility in Puerto
Rico. The company expects the CHP system to help significantly
reduce its carbon footprint in the coming years.
"At CooperCompanies, we are committed to working diligently to
positively impact the world around us," said Al White, President
and CEO of CooperCompanies. "In 2022, we continued making great
progress and we're proud of the success we've had, and the
direction in which we're moving. Conducting business in a socially
and environmentally responsible manner is important to our
long-term business success, and to the future of our planet."
The 2022 ESG Report includes expanded and updated ESG
performance data and provides stories across the company's ESG
pillars: People, Planet, and Partnerships. The report is aligned
with the Sustainability Accounting Standards Board (SASB)
Standards, a leading framework that identifies important ESG issues
most relevant to investors.
Read more in the Cooper 2022 ESG Report:
https://coopercos.com/esg/.
About CooperCompaniesCooperCompanies ("Cooper")
is a global medical device company publicly traded on the NYSE
(NYSE: COO). Cooper operates through two business units,
CooperVision and CooperSurgical. CooperVision brings a refreshing
perspective on vision care with a commitment to developing a wide
range of high-quality products for contact lens wearers and
providing focused practitioner support. CooperSurgical is committed
to advancing the health of women, babies and families with its
diversified portfolio of products and services focusing on medical
devices and fertility & genomics. Headquartered in San Ramon,
CA, Cooper has a workforce of more than 14,000 with products sold
in over 100 countries. For more information, please visit
www.coopercos.com.
Forward Looking StatementsThis press release
contains “forward-looking statements” as defined by the Private
Securities Litigation Reform Act of 1995. Statements relating to
guidance, plans, prospects, goals, strategies, future actions,
events or performance and other statements of which are other than
statements of historical fact, including all statements regarding
planned ESG programs and goals, the anticipated impact of ESG
activities, and product and technology plans, are forward-looking.
To identify these statements, look for words like “believes,”
“outlook,” “probable,” “expects,” “may,” “will,” “should,” “could,”
“seeks,” “intends,” “plans,” “estimates,” or “anticipates” and
similar words or phrases. Forward-looking statements necessarily
depend on assumptions, data, or methods that may be incorrect or
imprecise and are subject to risks and uncertainties. Among the
factors that could cause our actual results and future actions to
differ materially from those described in forward-looking
statements are: adverse changes in the global or regional general
business, political, and economic conditions including the impact
of continuing uncertainty and instability of certain countries,
man-made or natural disasters and pandemic conditions, that could
adversely affect our global markets, and the potential adverse
economic impact and related uncertainty caused by these items; the
impact of Russia's invasion of Ukraine and the global response to
this invasion on the global economy, European economy, financial
markets, energy markets, currency rates, and our ability to supply
product to, or through, affected countries; compliance costs and
potential liability in connection with U.S., and foreign laws and
healthcare regulations pertaining to privacy and security of
personal information; a major disruption in the operations of our
manufacturing, accounting, and financial reporting, research, and
development, distribution facilities or raw material supply chain;
disruptions in supplies of raw materials, particularly components
used to manufacture our silicone hydrogel lenses; new U.S. and
foreign government laws and regulations, and changes in existing
laws, regulations, and enforcement guidance, which affect areas of
our operations including, but not limited to, those affecting the
healthcare industry; new competitors, product innovations or
technologies; reduced sales, loss of customers, and costs and
expenses related to product recalls and warning letters; failure to
receive, or delays in receiving, regulatory approvals or
certifications for products; risks related to ESG issues, including
those related to climate change and sustainability; and other
events described in our Securities and Exchange Commission filings,
including the “Business,” “Risk Factors,” and "Management's
Discussion and Analysis of Financial Condition and Results of
Operations" sections in the our Annual Report on Form 10-K for the
fiscal year ended October 31, 2022. As such, Risk Factors may be
updated in annual and quarterly filings. We caution investors that
forward-looking statements reflect our analysis only on their
stated date. We disclaim any intent to update them except as
required by law.
Contact:Kim DuncanVice President, Investor Relations and Risk
Management925-460-3663ir@cooperco.com
Cooper Companies (NYSE:COO)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Cooper Companies (NYSE:COO)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024